Spectrum Pharmaceuticals, Inc. (SPPI) financial statements (2020 and earlier)

Company profile

Business Address 11500 S. EASTERN AVE., SUITE 240
HENDERSON, NV 89052
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:224204228158140133160
Cash and cash equivalents  227158140130156
Short-term investments31460  33
Other undisclosed cash, cash equivalents, and short-term investments193158     
Receivables0303240307149
Inventory, net of allowances, customer advances and progress billings 4694914
Inventory 4694914
Prepaid expense101010444 
Deposits current assets      0
Other current assets     1813
Other undisclosed current assets1042613(12)(0)
Total current assets:244251278217191222235
Noncurrent Assets
Operating lease, right-of-use asset4
Property, plant and equipment12010112
Intangible assets, net (including goodwill) 130155182208248250
Goodwill 181818181819
Intangible assets, net (excluding goodwill) 112137164190230231
Regulated entity, other noncurrent assets     23
Other noncurrent assets4105430211813
Other undisclosed noncurrent assets     (2)(3)
Total noncurrent assets:19140210212230268264
TOTAL ASSETS:263391487429421490499
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4162524842270
Accounts payable32453430279 
Accrued liabilities189979 
Employee-related liabilities8109988 
Taxes payable      0
Debt2 38    
Deferred compensation liability  58754
Deferred revenue and credits436100
Contract with customer, liability5
Other undisclosed current liabilities2019116226886
Total current liabilities:6286110667610990
Noncurrent Liabilities
Liabilities, other than long-term debt116717151810
Deferred revenue and credits00000
Deferred compensation liability, classified     54
Deferred tax liabilities, net  777 
Other liabilities116610766
Other undisclosed noncurrent liabilities 1620111117108117
Total noncurrent liabilities:112126127132126128
Total liabilities:73108136193208235218
Stockholders' equity
Stockholders' equity attributable to parent, including:190283351236213255282
Common stock0000000
Additional paid in capital918887837640552539518
Accumulated other comprehensive income (loss)(3)(4)16(2)(5)(1)1
Accumulated deficit(724)(600)(502)(403)(334)(283)(238)
Other undisclosed stockholders' equity attributable to parent    000
Total stockholders' equity:190283351236213255282
TOTAL LIABILITIES AND EQUITY:263391487429421490499

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 109128146137187143
Revenue, net128146163187156
Cost of revenue(0)(19)(39)(62)(66)(26)(26)
Cost of goods and services sold  (32)(34)(38)(24)(20)
Gross profit:(0)91898571160117
Operating expenses(141)(222)(186)(146)(137)(192)(168)
Other undisclosed operating income    26012
Operating loss:(141)(131)(97)(62)(41)(32)(39)
Nonoperating income (expense)(4)11(11)(9)(10)(12)2
Investment income, nonoperating      (0)
Foreign currency transaction loss, before tax     (6) 
Other nonoperating income (expense)(9)1001(1)(4)1
Interest and debt expense (3)(8)(10)(9)(9)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes      0
Loss from continuing operations before equity method investments, income taxes:(145)(123)(116)(81)(60)(53)(37)
Other undisclosed income from continuing operations before income taxes 381099 
Loss from continuing operations before income taxes:(145)(120)(108)(71)(50)(44)(37)
Income tax expense (benefit)9(0)172(0)(2)(25)
Net loss:(135)(120)(91)(69)(51)(46)(62)
Other undisclosed net income attributable to parent23      
Net loss available to common stockholders, diluted:(113)(120)(91)(69)(51)(46)(62)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(135)(120)(91)(69)(51)(46)(62)
Other comprehensive income (loss)     (2)1
Comprehensive loss:(135)(120)(91)(69)(51)(47)(62)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent23(2)184(4)  
Comprehensive loss, net of tax, attributable to parent:(112)(123)(74)(65)(55)(47)(62)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: